Article Data

  • Views 1458
  • Dowloads 152

Original Research

Open Access

Prenatal echocardiography – the impact on neonatal management

  • IWONA JAŃCZEWSKA1
  • IWONA DOMŻALSKA-POPADIUK1
  • ZBIGNIEW ŚWIĄTEK-BRZEZIŃSKI2

1Department of Neonatology, Medical University of Gdańsk, Poland

2 Department of Pediatric Cardiology and Congenital Heart Defects, Medical University of Gdańsk, Poland

DOI: 10.22514/SV142.102018.8 Vol.14,Issue 2,November 2018 pp.51-60

Published: 02 November 2018

*Corresponding Author(s): IWONA JAŃCZEWSKA E-mail: ijan@gumed.edu.pl

Abstract

Congenital heart disease (CHD) results in neonatal morbidity and mortality. Prenatal diagnosis allows preparing an appropriate perinatal and postnatal care. Babies born in low-risk level sites with unexpected CHD may have poorer outcomes. The pur-pose of this study was to compare results of foetal echocardiography to postnatal findings and assess the impact of antenatal suspicions of CHD on postnatal manage-ment. Medical records of mother-infant pairs with CHD admitted to the Neonatal Intensive Care Unit (NICU) of the Medi-cal University of Gdansk from 01.01. to 31.12.2013 were reviewed. We analysed if the defect was detected pre- or postnatally, and if the diagnosis was made by the ob-stetrician from low-risk level sites (level I) or from a tertiary care centre (level II so-nography). The overall incidence of CHD was 68 (3,4%). Critical congenital heart de-fects (CCHD) were found in 24 neonates (1,2%), 21 were diagnosed prenatally, 3 were transferred from 1st level units. Correlation between prenatal diagnosis made at our centre and postnatal findings was achieved in 47,7%. Accuracy in all prenatal and postnatal findings for both I and II sonography levels was 35,2%. There were major differences in the dispropor-tion of the great vessels and postnatal confirmation of coarctation of the aorta (CoAo) (7,1%). We obtained a high ac-curacy of prenatal and postnatal findings in detection of lesions such as Tetralogy of Fallot (ToF), transposition of the great ar-teries (TGA), DORV (double outlet right ventricle) and Critical Pulmonary Steno-sis, which require an outflow tract view (92,9% of cases). Conclusions: We con-firmed increasing diagnostic rates when the diagnostics is performed at a tertiary care centre. These results are in agreement with literature stating that prenatal detec-tion of CoAo is still challenging. Despite the high rates of misdiagnosis, ma-jority of infants benefited from prenatally diagnosed CCHD. 

Keywords

critical congenital heart disease, foetal, neonatal echocardiography, prenatal diagnosis.

Cite and Share

IWONA JAŃCZEWSKA,IWONA DOMŻALSKA-POPADIUK,ZBIGNIEW ŚWIĄTEK-BRZEZIŃSKI. Prenatal echocardiography – the impact on neonatal management. Signa Vitae. 2018. 14(2);51-60.

References

1. Meberg A, Lindberg H, Thaulow, E. Congenital heart defects: The patients who die. Acta Paediatr 2007;94(8):1060–65. http://doi. org/10.1111/j.1651-2227.2005.tb02046.x

2. Khoshnood B, Lelong N, Houyel L, Thieulin AC, Jouannic JM, Magnier S, et al. Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study. Heart 2012;98(22):1667-73.

3. Pinto NM, Keenan HT, Minich LL, Puchalski MD, Heywood M, Botto LD. Barriers to prenatal detection of congenital heart dis-ease: a population-based study. Ultrasound Obstet Gynecol 2012;40(4):418–25. http://doi.org/10.1002/uog.10116

4. Buyens A, Gyselaers W, Coumans A, Al Nasiry, S, Willekes C, Boshoff, D, et al. Difficult prenatal diagnosis: fetal coarctation. Facts Views Vis Obgyn. 2012;4(4):230–6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24753914

5. Evans W, Castillo W, Rollins R, Luna C, Kip K, Ludwick J, et al Moving towards universal prenatal detection of critical congenital heart disease in southern Nevada: a community-wide program. Pediatr Cardiol 2015;36(2):281-8. doi:10.1007/s00246-014-0996-1.

6. Hill GD, Block JR, Tanem JB, Frommelt MA. Disparities in the prenatal detection of critical congenital heart disease. Prenat Diagn 2015;35(9):859-63. doi:10.1002/pd.4622.

7. Colby C. E, Carey WA, Blumenfeld YJ, Hintz SR. Infants with prenatally diagnosed anomalies: special approaches to preparation and resuscitation. Clin Perinatol 2012;39(4):871–87. http://doi.org/10.1016/j.clp.2012.09.012

8. Donofrio MT, Levy RJ, Schuette JJ, Skurow-Todd K, Sten M-B, Stallings C, et al. Specialized delivery room planning for fetuses with critical congenital heart disease. Am J Cardiol 2013;111(5):737–47. http://doi.org/10.1016/j.amjcard.2012.11.029

9. Allan LD, Huggon IC. Counselling following a diagnosis of congenital heart disease. Prenat Diagn 2004;24(13):1136–42. http://doi.org/10.1002/pd.1071

10. Meberg A. Critical heart defects-the diagnostic challenge. Acta Paediatr. 2008;97(11):1480-83. doi:10.1111/j.1651-2227.2008.00975.x.

11. Słodki M, Respondek-Liberska M, Pruetz JD, Donofrio MT. 2016; Fetal cardiology: changing the definition of critical heart disease in the newborn. J Perinatol 36(8): 575–80. http://doi.org/10.1038/jp.2016.20

12. Berkley EMF, Goens MB, Karr S, Rappaport V. Utility of fetal echocardiography in postnatal management of infants with prenatally diagnosed congenital heart disease. Prenat Diagn 2009;29(7):654–8. http://doi.org/10.1002/pd.2260

13. Tworetzky W, McElhinney DB, Reddy VM, Brook MM, Hanley FL, Silverman NH. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001;103(9):1269-73. http://www.ncbi.nlm.nih.gov/pubmed/11238272.

14. Garne E, Stoll C, Clementi M, Euroscan Group. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experi-ence from 20 European registries. Ultrasound Obstet Gynecol 2001;17(5):386–91. http://doi.org/10.1046/j.1469-0705.2001.00385.x

15. Oster ME, Kim CH, Kusano AS, Cragan JD, Dressler P, Hales AR, et al. A population-based study of the association of prenatal diagnosis with survival rate for infants with congenital heart defects. Am J Cardiol 2014;113(6):1036–40. http://doi.org/10.1016/j. amjcard.2013.11.066

16. Friedberg MK, Silverman NH, Moon-Grady AJ, Tong E, Nourse J, Sorenson B, et al. Prenatal detection of congenital heart disease. J Pediatr 2009;155(1):26–31.e1. http://doi.org/10.1016/j.jpeds.2009.01.050

17. Marek J, Tomek V, Skovránek J, Povysilová V, Samánek M. Prenatal ultrasound screening of congenital heart disease in an unse-lected national population: a 21-year experience. Heart 2011;97(2):124-30. doi:10.1136/hrt.2010.206623.

18. Acherman RJ, Evans WN, Luna CF, Rollins R, Kip K, Collazos J, et al.Prenatal detection of congenital heart disease in southern Nevada: the need for universal fetal cardiac evaluation. J Ultrasound Med 2007;26(12):1715-9-1. http://www.ncbi.nlm.nih.gov/pubmed/18029923.

19. Dolk H, Loane M, Garne E. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 2011;123(8):841-9. doi:10.1161/CIRCULATIONAHA.110.958405.

20. Trivedi N, Levy D, Tarsa M, Anton T, Hartney C, Wolfson T, et al. Congenital cardiac anomalies: prenatal readings versus neonatal outcomes. J Ultrasound Med 2012;31(3):389–99. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22368129

21. Meyer-Wittkopf M, Cooper S, Sholler G. Correlation between fetal cardiac diagnosis by obstetric and pediatric cardiologist so-nographers and comparison with postnatal findings. Ultrasound Obstet Gynecol 2001;17(5):392–7. http://doi.org/10.1046 /j.1469-0705.2001.00381.

22. Friedman AH, Kleinman CS, Copel JA. Diagnosis of cardiac defects: where we’ve been, where we are and where we’re going. Prenat Diagn 2002;22(4):280–4. http://doi.org/10.1002/pd.305

23. Gonçalves LF, Bronsteen R, Lee W. Fetal heart: a 4-chamber view is not enough. Clin Obstet Gynecol 2012;55(1):266-280. doi:10.1097/GRF.0b013e3182446df0.

24. Simpson JM. Impact of fetal echocardiography. Ann Pediatr Cardiol 2009;2(1):41-50. doi:10.4103/0974-2069.52806.

25. Allan L, Dangel J, Fesslova V, Marek J, Mellander M, Oberhansli I, et al. Recommendations for the practice of fetal cardiology in Europe. Cardiol Young 2004;14(1):109-14. http://www.ncbi.nlm.nih.gov/pubmed/15237685.

26. Slodki M, Rychik J, Moszura T, Janiak K, Respondek-Liberska M. Measurement of the great vessels in the mediastinum could help distinguish true from false-positive coarctation of the aorta in the third trimester. J Ultrasound Med 2009;28(10):1313-17. http://www.ncbi.nlm.nih.gov/pubmed/19778876.

27. Chung ML, Lee BS, Kim EA-R, Kim K-S, Pi S-Y, Oh YM, et al. Impact of fetal echocardiography on trends in disease patterns and out-comes of congenital heart disease in a neonatal intensive care unit. Neonatology 2010;98(1):41–6. http://doi.org/10.1159/000264673

28. Clur SA, Van Brussel PM, Ottenkamp J, Bilardo CM. Prenatal diagnosis of cardiac defects: accuracy and benefit. Prenat Diagn 2012;32(5):450-5. doi:10.1002/pd.3837.

29. Holland BJ, Myers JA, Woods CR. Prenatal diagnosis of critical congenital heart disease reduces risk of death from cardiovascular compromise prior to planned neonatal cardiac surgery: a meta-analysis. Ultrasound Obstet Gynecol 2015;45(6):631-8. doi:10.1002/uog.14882.

30. Mahle WT, Clancy RR, McGaurn SP, Goin JE, Clark BJ. Impact of prenatal diagnosis on survival and early neurologic mor-bidity in neonates with the hypoplastic left heart syndrome. Pediatrics 2001;107(6):1277-82. http://www.ncbi.nlm.nih.gov/pub-med/11389243.

31. Franklin O, Burch M, Manning N, Sleeman K, Gould S, Archer N. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 2002;87(1):67-9. http://www.ncbi.nlm.nih.gov/pubmed/11751670.

32. Escobar-Diaz MC, Freud LR, Bueno A, Brown D, Friedman K, Schidlow D, et al. Prenatal diagnosis of transposition of the great arteries over a 20-year period: improved but imperfect. Ultrasound Obstet Gynecol 2015;45(6):678-82. doi:10.1002/uog.14751.

33. McGovern E, Sands AJ. Perinatal management of major congenital heart disease. Ulster Med J 2014;83(3):135-9. http://www.pub-medcentral.nih.gov/articlerender.fcgi?artid=4255832&tool=pmcentrez&rendertype=abstract. Accessed January 4, 2016.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top